Press Room

Press Clipping / May 11, 2020

Hovione helping out HSE and community groups with donations of hand sanitiser

Echo Live, May 11, 2020

A PHARMACEUTICAL company has donated hand sanitiser to the HSE as well as local organisations to help the fight against Covid-19.

Douglas GAA, camogie and ladies football clubs recently received a large donation of hand sanitiser for those that are helping out in their community during the pandemic.

Hovione is a contract pharmaceutical manufacturing company which helps bring new and off-patent drugs to market. 

Hovione, based in Ringaskiddy, has been manufacturing in Cork for 11 years and has more than  60 years experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.

Hovione employs more than 200 people in Cork and approximately 1,800 globally including Lisbon and Loures in Portugal; Macau in China and New Jersey in America.

Hovione initially began manufacturing hand sanitiser for the protection of team members on site with dispensers placed across the site. 

Since then the demand for hand sanitiser grew in our external community. This lead Hovione to appoint a project team to bring the manufacturing of hand sanitiser to distribution, so that it was readily available for donation to help protect various facilities and institutions across Ireland.

Key dates: April 11 – first day of Manufacturing - 17 days after the project kicked off.

April 20  – First batch of hand sanitiser was collected for use at St Stephen’s Hospital, Glanmire.

A spokesperson for the companys said: "A special thanks to the Hovione’s Project team, Site Leadership Team, Manufacturing and Warehouse Teams for all they have done to help with this fight against Covid-19. 

"A heartfelt thank you from all at Hovione must be given to the various suppliers who have helped us fight Covid-19 together - SciChem Laboratory Supplies, OCON Chemicals Ltd, Carbon Group, Quitmann O’Neill Packaging Ltd, Schuetz Packaging and South Coast Sales.

"To date Hovione have supplied 17,000 litres across Ireland to nursing homes, care facilities, charities and hospitals. Hovione are working closely with An Garda Síochána to safely distribute hand sanitiser to the HSE across Ireland with 11,000 litres of hand sanitiser  collected from site recently.

"On an international scale Hovione are distributing hand sanitiser free across all of our sites to support the local communities of each country we manufacture in."

Chairman of Douglas GAA Club, Aidan O'Connor thanks Hovione for their generous donation to the various clubs.

 

Read the article published at EchoLive.ie

Hovione helping out HSE and community groups with donations of hand sanitiser | Hovione
Rory Noonan, second left, receiving a donation of hand sanitiser from Hovione Éireann to Douglas GAA, Camogie and Ladies Football Clubs for members who are helping out in their local community. Representing Hovione Éireann were: Conor Crosbie, project manager; Willie Walsh, warehouse operator and Michelle McEvoy, analytical chemist. Picture: Barry O’Donoghue

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025